190 related articles for article (PubMed ID: 19012403)
41. [Contents of furanocoumarins in grapefruit juice and health foods].
Sakamaki N; Nakazato M; Matsumoto H; Hagino K; Hirata K; Ushiyama H
Shokuhin Eiseigaku Zasshi; 2008 Aug; 49(4):326-31. PubMed ID: 18787320
[TBL] [Abstract][Full Text] [Related]
42. Physiologically Based Pharmacokinetic Modeling of Bergamottin and 6,7-Dihydroxybergamottin to Describe CYP3A4 Mediated Grapefruit-Drug Interactions.
Fuhr LM; Marok FZ; Fuhr U; Selzer D; Lehr T
Clin Pharmacol Ther; 2023 Aug; 114(2):470-482. PubMed ID: 37307228
[TBL] [Abstract][Full Text] [Related]
43. Minor furanocoumarins and coumarins in grapefruit peel oil as inhibitors of human cytochrome P450 3A4.
César TB; Manthey JA; Myung K
J Nat Prod; 2009 Sep; 72(9):1702-4. PubMed ID: 19689106
[TBL] [Abstract][Full Text] [Related]
44. [Grapefruit juice interactions with psychotropic drugs: advantages and potential risk].
Pawełczyk T; Kłoszewska I
Przegl Lek; 2008; 65(2):92-5. PubMed ID: 18663908
[TBL] [Abstract][Full Text] [Related]
45. Lack of CYP3A4 inhibition by grapefruit juice and ketoconazole upon clozapine administration in vivo.
Lane HY; Chiu CC; Kazmi Y; Desai H; Lam YW; Jann MW; Chang WH
Drug Metabol Drug Interact; 2001; 18(3-4):263-78. PubMed ID: 11791889
[TBL] [Abstract][Full Text] [Related]
46. Effects of Citri Reticulatae Pericarpium and grapefruit juice on the pharmacokinetics of omeprazole in rats.
Zhang Y; Yu Y; Li H; Huang W; Wang P
J Food Biochem; 2022 Mar; 46(3):e13804. PubMed ID: 34080214
[TBL] [Abstract][Full Text] [Related]
47. In vitro interactions with repeated grapefruit juice administration--to peel or not to peel?
Brill S; Zimmermann C; Berger K; Drewe J; Gutmann H
Planta Med; 2009 Mar; 75(4):332-5. PubMed ID: 19148864
[TBL] [Abstract][Full Text] [Related]
48. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.
Ohnishi A; Matsuo H; Yamada S; Takanaga H; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Br J Pharmacol; 2000 Jul; 130(6):1369-77. PubMed ID: 10903978
[TBL] [Abstract][Full Text] [Related]
49. Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone.
Benmebarek M; Devaud C; Gex-Fabry M; Powell Golay K; Brogli C; Baumann P; Gravier B; Eap CB
Clin Pharmacol Ther; 2004 Jul; 76(1):55-63. PubMed ID: 15229464
[TBL] [Abstract][Full Text] [Related]
50. Toxicological and Pharmacokinetic Evaluation of Concomitant Intake of Grapefruit Juice and Simvastatin in Rats after Repeated Treatment over 28 Days.
Butterweck V; Zdrojewski I; Galloway C; Frye R; Derendorf H
Planta Med; 2009 Sep; 75(11):1196-202. PubMed ID: 19350484
[TBL] [Abstract][Full Text] [Related]
51. Determination of bergamottin in human plasma after grapefruit juice ingestion by an UPLC/MS/MS method.
Uesawa Y; Yamada H; Mohri K
Pharmazie; 2008 Feb; 63(2):110-2. PubMed ID: 18380396
[TBL] [Abstract][Full Text] [Related]
52. Assessment of a candidate marker constituent predictive of a dietary substance-drug interaction: case study with grapefruit juice and CYP3A4 drug substrates.
Ainslie GR; Wolf KK; Li Y; Connolly EA; Scarlett YV; Hull JH; Paine MF
J Pharmacol Exp Ther; 2014 Dec; 351(3):576-84. PubMed ID: 25253884
[TBL] [Abstract][Full Text] [Related]
53. [Furanocoumarins contents and cytochrome P450 3A (CYP3A) inhibitory activities of various processed fruit peel products: outflow of 6',7'-Dihydroxybergamottin during processing treatment of peel].
Ishihara M; Toda H; Sunagane N; Ohta T
Yakugaku Zasshi; 2011; 131(5):679-84. PubMed ID: 21532264
[TBL] [Abstract][Full Text] [Related]
54. The effect of grapefruit juice on drug disposition.
Hanley MJ; Cancalon P; Widmer WW; Greenblatt DJ
Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):267-86. PubMed ID: 21254874
[TBL] [Abstract][Full Text] [Related]
55. Rapid Quantitation of Furanocoumarins and Flavonoids in Grapefruit Juice using Ultra-Performance Liquid Chromatography.
Vandermolen KM; Cech NB; Paine MF; Oberlies NH
Phytochem Anal; 2013; 24(6):654-60. PubMed ID: 23780830
[TBL] [Abstract][Full Text] [Related]
56. Long-lasting inhibitory effect of apple and orange juices, but not grapefruit juice, on OATP2B1-mediated drug absorption.
Shirasaka Y; Shichiri M; Murata Y; Mori T; Nakanishi T; Tamai I
Drug Metab Dispos; 2013 Mar; 41(3):615-21. PubMed ID: 23264447
[TBL] [Abstract][Full Text] [Related]
57. Labeled content of two furanocoumarins in dietary supplements correlates with neither actual content nor CYP3A inhibitory activity.
VanderMolen KM; Ainslie GR; Paine MF; Oberlies NH
J Pharm Biomed Anal; 2014 Sep; 98():260-5. PubMed ID: 24951959
[TBL] [Abstract][Full Text] [Related]
58. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice.
Bailey DG; Dresser GK; Leake BF; Kim RB
Clin Pharmacol Ther; 2007 Apr; 81(4):495-502. PubMed ID: 17301733
[TBL] [Abstract][Full Text] [Related]
59. Management of grapefruit-drug interactions.
Stump AL; Mayo T; Blum A
Am Fam Physician; 2006 Aug; 74(4):605-8. PubMed ID: 16939181
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model.
Takanaga H; Ohnishi A; Matsuo H; Murakami H; Sata H; Kuroda K; Urae A; Higuchi S; Sawada Y
Br J Clin Pharmacol; 2000 Jan; 49(1):49-58. PubMed ID: 10606837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
